Stock AEON AEON BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus AEON Biopharma, Inc.

Equities

AEON

US00791X1000

Market Closed - Nyse
Other stock markets
 04:00:00 2024-06-07 pm EDT 		5-day change 1st Jan Change
1.68 USD +2.44% Intraday chart for AEON Biopharma, Inc. +6.33% -76.67%
May. 16 AEON Biopharma, Inc. Announces Termination of Peter Reynolds as Chief Financial Officer, Effective May 17, 2024 CI
May. 16 AEON Biopharma, Inc. Announces Executive Changes CI

Evolution of the average Target Price on AEON Biopharma, Inc.

Price target over the last 5 years

History of analyst recommendation changes

e442afa2ec58483ac5167492bd78bd.XRBefoyI5SuaNL8bORJuHNhNlj-nyBFdOi1i_6H-GX8.PCkNF-T8gHvfUNFPDHQ-bK4CwWjtjTwocm8arJOPaz0cXw86-uOrbdNR2A~104426da9166ba85b7d1bbf96d65f9dd

Analyst Recommendations on AEON Biopharma, Inc.

HC Wainwright Starts AEON Biopharma at Buy With $18 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1.68 USD
Average target price
6 USD
Spread / Average Target
+257.14%
High Price Target
6 USD
Spread / Highest target
+257.14%
Low Price Target
6 USD
Spread / Lowest Target
+257.14%

Consensus detail

Consensus revision (last 18 months)

Analysts covering AEON Biopharma, Inc.

HC Wainwright

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. AEON Stock
  4. Consensus AEON Biopharma, Inc.